{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fquadshot-news-podcast.simplecast.com%2Fepisodes%2F412024-natalee-uGyMHbNA","width":444,"version":"1.0","type":"rich","title":"4.1.2024 - NATALEE","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/d4956b26-f7a3-4f47-a83d-9293649d65c8/ec08e780-4e06-4c01-8109-4e894d682296/qs_sqaure.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/c04af01d-abfd-47df-ae24-5e45d7445000\" height=\"200\" width=\"100%\" title=\"4.1.2024 - NATALEE\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Check out the latest QuadCast where we highlight the results of the NATALEE trial, long term CONVERT results for SCLC, Gray Matter changes after SRS for Trigeminal Neuralgia, and more."}